Trial to deliberately infect people with coronavirus draws mixed reaction

A masked woman looks away as another woman in a mask sticks a needle in her arm.

Enlarge / Woman receives an experimental COVID-19 vaccine at the University of Massachusetts Medical School in Worcester, MA, on September 04, 2020, as part of a clinical trial. (credit: Getty | Boston Globe)

Researchers in the United Kingdom plan to begin intentionally infecting a small batch of healthy young people with the novel coronavirus in January as part of a first “human challenge trial,” according to an announcement Monday.

The plan has not yet been approved by the Medicines and Healthcare Regulatory Agency (MHRA), which regulates clinical trials in the UK, and outside experts have had mixed reactions to the announcement so far.

Nevertheless, the UK government is planning to invest $43.4 million (33.6 million pounds) in the trials. Researchers meanwhile are preparing to recruit an initial 30 to 50 people, aged 18 to 30, who have no underlying health conditions. Those conditions include diabetes, heart disease, or obesity, all of which would put them at greater risk of the pandemic coronavirus, SARS-CoV-2, and the disease it causes, COVID-19.

Read 16 remaining paragraphs | Comments

Read More
Ars Technica

You May Also Like:   PS5 had the biggest console launch in UK history, according to industry sources

Leave a Reply

Your email address will not be published. Required fields are marked *